OGIVRI® (trastuzumab-dkst)
What is OGIVRI? ADJUVANT BREAST CANCER . OGIVRI is a prescription medicine used for the treatment of adjuvant breast cancer. OGIVRI is used for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes or is HER2-positive and has not spread into the lymph ...
OGIVRI ® (trastuzumab-dkst) Side Effects
What is OGIVRI? ADJUVANT BREAST CANCER . OGIVRI is a prescription medicine used for the treatment of adjuvant breast cancer. OGIVRI is used for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes or is HER2-positive and has not spread into the lymph ...
How OGIVRI ® (trastuzumab-dkst) works
What is OGIVRI? ADJUVANT BREAST CANCER . OGIVRI is a prescription medicine used for the treatment of adjuvant breast cancer. OGIVRI is used for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes or is HER2-positive and has not spread into the lymph ...
Home [www.ogivri.com]
Home